1933 Industries Inc.
Other OTCCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- CEO
- Brian Farrell
- Full Time Employees
- 85
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- 1055 West Hastings Street Vancouver BC Canada V6E 2E9
- IPO Date
- May 22, 2013
- CIK
- 0001706145
- Website
- 1933industries.com
- Similar Companies
- Business
- 1933 Industries Inc. engages in the cultivation, extraction, production, and wholesale distribution of cannabis consumer-packaged goods primarily in Nevada. The company offers a portfolio exceeding 100 SKUs including flower, infused pre-rolls, boutique concentrates under the flagship Alternative Medicine Association (AMA) brand; Level X branded products; and Canna Hemp wellness items such as tinctures, gummies, topicals, and sports recovery products containing cannabidiol (CBD), cannabigerol (CBG), and cannabinol (CBN), marketed through licensed dispensaries and direct-to-consumer ecommerce at cannahemp.com. Operations span cultivation and manufacturing at a 68,000 square foot indoor facility in Las Vegas, Nevada; extraction and processing via wholly owned subsidiaries Alternative Medicine Association LC (AMA) and Infused MFG LLC; with sales focused on medical and adult-use markets in the United States. Founded in 2008 and headquartered in Vancouver, British Columbia, Canada, the company lists on the Canadian Securities Exchange (TGIF) and OTC Markets (TGIFF). In 2025, 1933 Industries completed the acquisition of the remaining 9% membership interest in AMA from former executive Caleb Zobrist for USD 50,000 in cash and shares through subsidiary FN Pharmaceuticals, achieving 100% ownership and full consolidation of its core cultivation and production operations.
1933 Industries Reports Second Quarter 2026 Financial Results
1933 Industries Provides Update on 2024 Debenture Conversions
1933 Industries Issues Final Reminder to 2024 Debenture Holders: December 22 Is the Deadline to Convert
1933 Industries Achieves Positive Income in Q1 2026, Marking Third Consecutive Profitable Quarter
1933 Industries Issues Reminder to Debenture Holders Ahead of December 22 Conversion Deadline and Highlights Positive Industry Developments
1933 Industries Announces Maturity of Unsecured Convertible Debentures and Encourages Conversion to Support Continued Growth
1933 Industries Announces Year End 2025 Financial Results and Reports Positive Income
1933 Industries Announces Repurchase and Cancellation of Convertible Debentures
1933 Industries Reminds Shareholders to Vote at the Upcoming Annual General Meeting
Ross & Co. Closes Restaurant In Hatboro
1933 Industries Reports Profit in Third Quarter 2025 Financial Results
1933 Industries Announces the Completion of the Purchase of 9% Interest of Cultivation and Production Subsidiary
1933 Industries To Complete Purchase of 9% Interest of Cultivation and Production Subsidiary
1933 Industries Reports Second Quarter 2025 Financial Results
CSE Bulletin: Reinstatement - 1933 Industries Inc. (TGIF)
1933 Industries Announces First Quarter 2025 Financial Report
1933 Industries Announces Fourth Quarter and 2024 Year-End Financial Results with Record Revenues of $19.3 Million
1933 Industries Appoints New CFO and VP Finance
1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report
1933 Industries Provides Update on Status of Filing Delay for 4th Quarterly Report